Ann Marie Louvet

Title: Ann Marie Louvet: Innovator in Pharmaceutical Chemistry

Introduction

Ann Marie Louvet is a distinguished inventor based in King of Prussia, PA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various medical conditions. With a total of 4 patents to her name, her work has had a meaningful impact on healthcare.

Latest Patents

Among her latest patents is the invention of carvedilol phosphate salts and/or solvates thereof, along with corresponding compositions and methods of treatment. This invention relates to novel crystalline forms of carvedilol dihydrogen phosphate, which is a dihydrogen phosphate salt of a specific compound. These salts and solvates are utilized in treating hypertension, congestive heart failure, and angina, showcasing her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Ann Marie Louvet has worked with notable companies such as SmithKline Beecham Ltd and Sb Pharmco Puerto Rico Inc. Her experience in these organizations has allowed her to hone her skills and contribute to significant advancements in pharmaceutical research and development.

Collaborations

Ann Marie has collaborated with esteemed colleagues, including Christopher S. Brook and Wei Chen. These partnerships have further enriched her research and innovation efforts in the pharmaceutical field.

Conclusion

Ann Marie Louvet's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a key innovator in the industry. Her work continues to influence the development of effective treatments for critical health conditions.